FMC and Corteva Partner to Expand Access to Rimisoxafen Herbicide Technology

Corporate ActionProduct / Tech
โดย Zacks Investment Research·Read original
Summary · why it matters

FMC Corporation and Corteva have announced a co-exclusive strategic supply and license agreement to expand access to FMC's rimisoxafen herbicide technology across North and South America. Under the agreement, FMC retains ownership of rimisoxafen and supplies the active ingredient to Corteva, while both companies independently develop and commercialize exclusive premix formulations for corn and soybean markets. Corteva will make an initial prepayment of $200 million for future product supply. Rimisoxafen is recognized as the industry's first dual mode of action herbicide, providing a higher barrier to resistance development. Pending regulatory approvals, the first commercial sales of rimisoxafen-based products are anticipated by the end of the decade.

Impact on stocks 5

Climate Adaptation & Water▲ · 1 stocks
FMC Corporation
FMC
▲ PositiveDemandrelevance

FMC licenses rimisoxafen to Corteva, securing $200M prepayment and expanding market reach

Synthetic Biology (non-pharma)▲ · 1 stocks
Corteva Inc
CTVA
▲ PositiveDemandrelevance

Corteva gains co-exclusive access to rimisoxafen herbicide technology, with $200M prepayment for future supply

Electrification & Mobility▲ · 1 stocks
Materials▲ · 1 stocks
Critical Materials & Supply Chain▲ · 1 stocks
© 2026 MarketDXNews